Cytokinetics, Incorporated (CYTK) Soars: Stock Up 26% in Session - Tale of the Tape
10 Februar 2014 - 2:51PM
Zacks
Cytokinetics,
Incorporated (CYTK) was a big mover last session, as its
shares surged over 26% on the day. The surge came on solid volume
too with far more shares changing hands than in a normal session.
This reverses the trend for the company since Jan 23, as the stock
is now down almost 4%.
In the last 30-day frame, the company witnessed one negative
estimate revision and the Zacks Consensus Estimate also moved
lower, signaling trouble down the road. So make sure to keep an eye
on this stock going forward to see if Friday’s move higher
lasts.
Cytokinetics currently has a Zacks Rank #3 (Hold) while its
Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include
Gentium S.p.A (GENT), Emergent
BioSolutions, Inc. (EBS) and Actelion
Ltd. (ALIOF). All three sport a Zacks Rank #1 (Strong
Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days. Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
CYTOKINETCS INC (CYTK): Free Stock Analysis Report
EMERGENT BIOSOL (EBS): Free Stock Analysis Report
GENTIUM SPA-ADR (GENT): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
(USOTC:ALIOF)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
(USOTC:ALIOF)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über (OTCMarkets): 0 Nachrichtenartikel
Weitere Actelion Ltd. (PC) News-Artikel